{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:23:36Z","timestamp":1777724616751,"version":"3.51.4"},"reference-count":15,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[1990,9]]},"abstract":"<jats:p>In a randomized, single-blind, parallel study the safety and efficacy of 2% butoconazole nitrate cream used for 3 days were compared with those of 1% econazole nitrate cream used for 7 days at night in patients with vulvovaginal candidiasis. Patients in both treatment groups had positive potassium hydroxide smears and fungal cultures, and were similar in age, disease duration and history, obstetric history and contraceptive use. Of the 75 patients enrolled, 63 with a Candida albicans infection were included in the efficacy analyses. Evaluations were made at the start of the study (visit 1), after 10 \u2013 23 days (visit 2) and after 24 \u2212 45 days (visit 3). Both drugs significantly reduced all signs and symptoms, and at visits 2 and 3 the percentages of patients considered microbiologically, clinically and therapeutically cured were consistently higher for butoconazole-than for econazole-treated patients, although differences were not statistically different. Although both drugs were safe and well tolerated, it is concluded that butoconazole because of its much shorter regimen and superior clinical and microbiological performance was the drug of choice.<\/jats:p>\n                  <jats:p>Lors d'une \u00e9tude parall\u00e8le randomis\u00e9e en simple aveugle, l'innocuit\u00e9 et l'efficacit\u00e9 du nitrate de butoconazole cr\u00e8me \u00e0 2% appliqu\u00e9 pendant 3 jours ont \u00e9t\u00e9 compar\u00e9es \u00e0 celles du nitrate d'\u00e9conazole cr\u00e8me \u00e0 1% administr\u00e9 la nuit pendant 7 jours \u00e0 des patientes pr\u00e9sentant une candidose vulvo-vaginale. Les deux groupes pr\u00e9sentaient des cultures et des frottis \u00e0 l'hydroxyde de potassium positifs et \u00e9taient comparables au point de vue \u00e2ge, dur\u00e9e et \u00e9volution de l'infection, ant\u00e9cedents obst\u00e9tricaux et utilisation de contraceptifs. Sur les 75 patientes trait\u00e9es, 63 pr\u00e9sentant une infection \u00e0 Candida albicans ont \u00e9t\u00e9 incluses dans l'analysis d'efficacit\u00e9. Des \u00e9valuations ont \u00e9t\u00e9 effectu\u00e9es au d\u00e9but de l'\u00e9tude (visite 1), apr\u00e8s 10 \u00e0 23 jours (visite 2), et apr\u00e8s 24 \u00e0 45 jours (visite 3). Les deux m\u00e9dicaments ont nettement r\u00e9duit tous les signes cliniques et les sympt\u00f4mes, et lors des visites 2 et 3 les pourcentages de patientes consid\u00e9r\u00e9es comme microbiologiquement, cliniquement et th\u00e9rapeutiquement gu\u00e9ries \u00e9taient r\u00e9guli\u00e8rement plus \u00e9lev\u00e9s chez celles trait\u00e9es avec le butoconazole que chez celles trait\u00e9es avec l'\u00e9conazole, bien que les diff\u00e9rences n'aient pas \u00e9t\u00e9 statistiquement significatives. Comme les deux produits se sont r\u00e9v\u00e9l\u00e9s sans danger et ont \u00e9t\u00e9 bien tol\u00e9r\u00e9s, nous conclusons que le butoconazole, \u00e0 cause de son effet beaucoup plus rapide et de ses performances cliniques et microbiologiques sup\u00e9rieures, constitue le traitement de choix.<\/jats:p>","DOI":"10.1177\/030006059001800507","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T04:49:54Z","timestamp":1484542194000},"page":"389-399","source":"Crossref","is-referenced-by-count":0,"title":["A Comparison of Butoconazole Nitrate Cream with Econazole Nitrate Cream for the Treatment of Vulvovaginal Candidiasis"],"prefix":"10.1177","volume":"18","author":[{"given":"H.","family":"Ruf","sequence":"first","affiliation":[{"name":"Belle de Mai Maternity Hospital, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vitse","sequence":"additional","affiliation":[{"name":"Gynaecology and Obstetrics Clinic, Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1990,9,1]]},"reference":[{"key":"bibr1-030006059001800507","first-page":"217","volume-title":"Benign Diseases of the Vulva and Vagina","author":"Gardner HL","year":"1981"},{"key":"bibr2-030006059001800507","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.3.397"},{"key":"bibr3-030006059001800507","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1976.tb00846.x"},{"key":"bibr4-030006059001800507","first-page":"530","volume":"64","author":"Droegemueller W","year":"1984","journal-title":"Obstet Gynecol"},{"key":"bibr5-030006059001800507","first-page":"67","volume":"19","author":"Sargent EC","year":"1977","journal-title":"J Reprod Med"},{"key":"bibr6-030006059001800507","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(85)80011-9"},{"key":"bibr7-030006059001800507","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(85)80010-7"},{"key":"bibr8-030006059001800507","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197816030-00001"},{"key":"bibr9-030006059001800507","first-page":"121","volume":"56","author":"Brown D","year":"1980","journal-title":"Obstet Gynecol"},{"key":"bibr10-030006059001800507","doi-asserted-by":"publisher","DOI":"10.1021\/jm00206a028"},{"key":"bibr11-030006059001800507","first-page":"655","volume":"31","author":"Matthews TR","journal-title":"J Reprod Med"},{"key":"bibr12-030006059001800507","doi-asserted-by":"crossref","unstructured":"Jacobson JB, Hajman AJ, Wiese J, A new vaginal antifungal agent \u2013 butoconazole nitrate. Acta Obstet Gynecol Scand 1985; 241\u2013244.","DOI":"10.3109\/00016348509155121"},{"key":"bibr13-030006059001800507","first-page":"270","volume":"61","author":"Bradbeer CS","year":"1985","journal-title":"Genitourin Med"},{"key":"bibr14-030006059001800507","volume-title":"Statistical Methods and Medical Research","author":"Armitage P","year":"1971","edition":"1"},{"key":"bibr15-030006059001800507","volume-title":"Nonparametric Statistics for the Behavioural Sciences.","author":"Siegel S","year":"1956"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/030006059001800507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/030006059001800507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:40:21Z","timestamp":1777459221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/030006059001800507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["10.1177\/030006059001800507"],"URL":"https:\/\/doi.org\/10.1177\/030006059001800507","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}